Skip to main content
Equibles

UBS Group AG

Position in PLUR — Pluri Inc.

CIK 1610520 ZURICH, V8
Back to PLUR Full portfolio

Position in PLUR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,008
+$3,686 QoQ
Shares Held
1,918
+1918.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 16 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PLUR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. PLUR ranks #476 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in PLUR

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,008 1,918
2026-03-31 $322 95
2025-12-31 $53 18
2025-09-30 $80 18
2025-06-30 $321 65
2025-03-31 $890 207
2024-12-31 $31,790 7,428
2024-09-30 $8,227 1,360
2024-06-30 $60,388 10,448
2024-03-31 $1,822 2,250
2023-12-31 $1,305 2,250
2023-09-30 $1,352 2,254
2023-06-30 $3,431 4,289
2023-03-31 $5,857 5,743
2022-12-31 $5,371 5,715
2022-09-30 $1,110 1,424